Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

LogicBio Therapeutics, Inc. - Common Stock (NQ: LOGC )

9.070 +0.580 (+6.83%)
Official Closing Price Updated: 4:00 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 169,800
Open 8.500
Bid (Size) 9.070 (11)
Ask (Size) 9.320 (1)
Prev. Close 8.490
Today's Range 8.310 - 9.150
52wk Range 3.050 - 11.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
LogicBio Announces Extension Of Collaboration With Children's Medical Research Institute
Collaboration seeks to develop next-generation viral vectors for gene therapy and gene editing applications in liver and two other tissues. 
From PR Newswire
LogicBio Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical stage genetic medicines company, today announced that president and chief executive officer Fred Chereau will present virtually at the 39th Annual... 
From PR Newswire

Performance

YTD
+9.94%
+9.94%
1 Month
+10.74%
+10.74%
3 Month
+57.74%
+57.74%
6 Month
+2.25%
+2.25%
1 Year
+18.72%
+18.72%

More News

Read More
Cecilia Jones Joins LogicBio Therapeutics as Chief Financial Officer
From PR Newswire
LogicBio Therapeutics names Daphne Karydas and Jeff Goater to Board of Directors
From PR Newswire
LogicBio Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
LogicBio Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA)
From GlobeNewswire News Releases
LogicBio Therapeutics Announces Appointment of Veteran Biotech Executive Mariana Nacht, Ph.D., as Chief Scientific Officer and Kyle Chiang, Ph.D., Promoted to Chief Operating Officer
From GlobeNewswire News Releases
LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Bullish Two Hundred Day Moving Average Cross - LOGC
Tags Stocks
From Market News Video
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Tags VTVT Movers GNFT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.